WHG
CABA icon

Westwood Holdings Group’s Cabaletta Bio CABA Stock Holding History

Westwood Holdings Group’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-170,129
Closed -$1.27M – 476
2024
Q2 		$1.27M Buy
170,129
+87,901
+107% +$1.08M 0.01% 346
2024
Q1 		$1.4M Buy
+82,228
New +$1.76M 0.01% 338

Other funds holding CABA

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Westwood Holdings Group's CABA Position: Q3 2024 in Review

Westwood Holdings Group sold out of Cabaletta Bio (CABA) in Q3 2024, closing a stake of 170,129 shares — an estimated $1.27M sold.

Westwood Holdings Group first reported a position in CABA in Q1 2024 and held it in 2 quarters. The position peaked at $1.4M in Q1 2024. 120 funds tracked by Wall St. Rank hold CABA as of Q3 2024.

  • Westwood Holdings Group reported no remaining Cabaletta Bio position as of Q3 2024 after selling out during the quarter.
  • Westwood Holdings Group sold 170,129 Cabaletta Bio shares in Q3 2024, an estimated $1.27M.
  • Westwood Holdings Group first reported a position in Cabaletta Bio in Q1 2024 and held it in 2 quarters.
  • Westwood Holdings Group's Cabaletta Bio position peaked at $1.4M in Q1 2024.
  • 120 funds tracked by Wall St. Rank held Cabaletta Bio as of Q3 2024.

Based on Westwood Holdings Group's 13F filing for Q3 2024, filed 14 Nov 2024.